Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice

Introduction Angiotensin II (Ang II) is known to induce cardiac growth and modulate myocardial contractility. It has been reported that elevated levels of endogenous Ang II contribute to the development of cardiac hypertrophy in hypertensives. However, the long-term functional effects of cardiac exp...

Full description

Bibliographic Details
Main Authors: Catherine E Huggins, Andrea A Domenighetti, Thierry Pedrazzini, Salvatore Pepe, Lea MD Delbridge
Format: Article
Language:English
Published: SAGE Publications 2003-09-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.3317/jraas.2003.030
_version_ 1797283624829059072
author Catherine E Huggins
Andrea A Domenighetti
Thierry Pedrazzini
Salvatore Pepe
Lea MD Delbridge
author_facet Catherine E Huggins
Andrea A Domenighetti
Thierry Pedrazzini
Salvatore Pepe
Lea MD Delbridge
author_sort Catherine E Huggins
collection DOAJ
description Introduction Angiotensin II (Ang II) is known to induce cardiac growth and modulate myocardial contractility. It has been reported that elevated levels of endogenous Ang II contribute to the development of cardiac hypertrophy in hypertensives. However, the long-term functional effects of cardiac exposure to Ang II in normotensives is unclear. A recently developed transgenic mouse (TG1306/1R), in which cardiac-specific overproduction of Ang II produces primary hypertrophy, provides a new experimental model for investigation of this phenotype. The aim of the present study was to use this model to investigate whether there is a functional deficit in primary hypertrophy that may predispose to cardiac failure and sudden death. We hypothesised that primary cardiac hypertrophy is associated with mechanical dysfunction in the basal state. Methods Normotensive heterozygous TG1306/1R mice harbouring multiple copies of a cardiac-specific rat angiotensinogen gene were studied at age 30—40 weeks and compared with age-matched wild-type littermates. Left ventricular function was measured ex vivo in bicarbonate buffer-perfused, Langendorffmounted hearts ( at a perfusion pressure of 80 mmHg, 37°C) using a fluid-filled PVC balloon interfaced to a pressure transducer and digital data acquisition system. Results There was no difference in the mean (±SEM) intrinsic heart rate of TG1306/1R and wild-type control mice (357.4±11.8 vs. 367.5±20.9 bpm, n=9 & 7). Under standardised end-diastolic pressure conditions, TG1306/1R hearts exhibited a significant reduction in peak developed pressure (132.2±9.4 vs. 161.5±3.1 mmHg, n=9 & 7, p<0.05) and maximum rate of pressure development (3566.7±323.7 vs. 4486.3±109.4 mmHg, n=9 & 7, p<0.05). TG1306/1R mice show a significant correlation between incidence of arrhythmia and increasing heart size (Spearman's correlation coefficient 0.61). Conclusion These data demonstrate that chronic in vivo exposure to elevated levels of intra-cardiac Ang II is associated with significant contractile abnormalities evident in the ex vivo intact heart. Our findings suggest that endogenous overproduction of cardiac Ang II, independent of changes in blood pressure, is sufficient to induce ventricular remodelling that culminates in impaired cardiac function which may precede failure.
first_indexed 2024-03-07T17:34:29Z
format Article
id doaj.art-d49e7de593524d27a46ba7f6e9a24600
institution Directory Open Access Journal
issn 1470-3203
language English
last_indexed 2024-03-07T17:34:29Z
publishDate 2003-09-01
publisher SAGE Publications
record_format Article
series Journal of the Renin-Angiotensin-Aldosterone System
spelling doaj.art-d49e7de593524d27a46ba7f6e9a246002024-03-02T17:16:27ZengSAGE PublicationsJournal of the Renin-Angiotensin-Aldosterone System1470-32032003-09-01410.3317/jraas.2003.030Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive miceCatherine E HugginsAndrea A DomenighettiThierry PedrazziniSalvatore PepeLea MD DelbridgeIntroduction Angiotensin II (Ang II) is known to induce cardiac growth and modulate myocardial contractility. It has been reported that elevated levels of endogenous Ang II contribute to the development of cardiac hypertrophy in hypertensives. However, the long-term functional effects of cardiac exposure to Ang II in normotensives is unclear. A recently developed transgenic mouse (TG1306/1R), in which cardiac-specific overproduction of Ang II produces primary hypertrophy, provides a new experimental model for investigation of this phenotype. The aim of the present study was to use this model to investigate whether there is a functional deficit in primary hypertrophy that may predispose to cardiac failure and sudden death. We hypothesised that primary cardiac hypertrophy is associated with mechanical dysfunction in the basal state. Methods Normotensive heterozygous TG1306/1R mice harbouring multiple copies of a cardiac-specific rat angiotensinogen gene were studied at age 30—40 weeks and compared with age-matched wild-type littermates. Left ventricular function was measured ex vivo in bicarbonate buffer-perfused, Langendorffmounted hearts ( at a perfusion pressure of 80 mmHg, 37°C) using a fluid-filled PVC balloon interfaced to a pressure transducer and digital data acquisition system. Results There was no difference in the mean (±SEM) intrinsic heart rate of TG1306/1R and wild-type control mice (357.4±11.8 vs. 367.5±20.9 bpm, n=9 & 7). Under standardised end-diastolic pressure conditions, TG1306/1R hearts exhibited a significant reduction in peak developed pressure (132.2±9.4 vs. 161.5±3.1 mmHg, n=9 & 7, p<0.05) and maximum rate of pressure development (3566.7±323.7 vs. 4486.3±109.4 mmHg, n=9 & 7, p<0.05). TG1306/1R mice show a significant correlation between incidence of arrhythmia and increasing heart size (Spearman's correlation coefficient 0.61). Conclusion These data demonstrate that chronic in vivo exposure to elevated levels of intra-cardiac Ang II is associated with significant contractile abnormalities evident in the ex vivo intact heart. Our findings suggest that endogenous overproduction of cardiac Ang II, independent of changes in blood pressure, is sufficient to induce ventricular remodelling that culminates in impaired cardiac function which may precede failure.https://doi.org/10.3317/jraas.2003.030
spellingShingle Catherine E Huggins
Andrea A Domenighetti
Thierry Pedrazzini
Salvatore Pepe
Lea MD Delbridge
Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice
Journal of the Renin-Angiotensin-Aldosterone System
title Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice
title_full Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice
title_fullStr Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice
title_full_unstemmed Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice
title_short Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice
title_sort elevated intracardiac angiotensin ii leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice
url https://doi.org/10.3317/jraas.2003.030
work_keys_str_mv AT catherineehuggins elevatedintracardiacangiotensiniileadstocardiachypertrophyandmechanicaldysfunctioninnormotensivemice
AT andreaadomenighetti elevatedintracardiacangiotensiniileadstocardiachypertrophyandmechanicaldysfunctioninnormotensivemice
AT thierrypedrazzini elevatedintracardiacangiotensiniileadstocardiachypertrophyandmechanicaldysfunctioninnormotensivemice
AT salvatorepepe elevatedintracardiacangiotensiniileadstocardiachypertrophyandmechanicaldysfunctioninnormotensivemice
AT leamddelbridge elevatedintracardiacangiotensiniileadstocardiachypertrophyandmechanicaldysfunctioninnormotensivemice